PARAFEND 9.06% ORAL SUSPENSION.
País: Irlanda
Língua: inglês
Origem: HPRA (Health Products Regulatory Authority)
Características técnicas
(SPC)
17-05-2024
No momento, alguns documentos para este produto não estão disponíveis, você pode enviar uma solicitação ao nosso serviço de atendimento ao cliente e iremos notificá-lo assim que conseguirmos obtê-los.
Enviar pedido.
Enviar pedido.
Ingredientes ativos:
OXFENDAZOLE
Disponível em:
Norbrook Laboratories Limited
Código ATC:
QP52AC02
DCI (Denominação Comum Internacional):
OXFENDAZOLE
Dosagem:
9.06 %w/v
Forma farmacêutica:
Oral Suspension
Tipo de prescrição:
LM-Licensed Merchant
Grupo terapêutico:
Bovine, Ovine
Área terapêutica:
Oxfendazole
Indicações terapêuticas:
Endoparasiticide
Status de autorização:
Authorised
Data de autorização:
1994-02-10
Características técnicas
IRISH MEDICINES BOARD ACT 1995
EUROPEAN COMMUNITIES (ANIMAL REMEDIES) (NO. 2) REGULATIONS 2007
(S.I. NO. 786 OF 2007)
VPA: 10999/061/001
Case No: 7005216
The Irish Medicines Board in exercise of the powers conferred on it by Animal Remedies (No. 2) Regulations (S.I. No. 786 of 2007) hereby
grants to:
NORBROOK LABORATORIES LIMITED
STATION WORKS, NEWRY, CO. DOWN BT35 6JP
an authorisation, subject to the provisions of the said Regulations and the general conditions of the attached authorisation, in respect of the
Veterinary Medicinal Product:
PARAFEND 9.06% ORAL SUSPENSION
The particulars of which are set out in Part 1 and Part 2 of the said Schedule. The authorisation is also subject to any special conditions as may
be specified in the said Schedule.
The authorisation, unless previously revoked, shall continue in force from 09/02/2009.
Signed on behalf of the Irish Medicines Board
________________
A person authorised in that behalf by the said Board.
(NOTE: From this date of effect, this authorisation replaces any previous authorisation in respect of this product which is now null and void.)
IRISH MEDICINES BOARD
________________________________________________________________________________________________________________________
_Date Printed 16/07/2009_
_CRN 7005216_
_page number: 1_
PART II
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Parafend 9.06% Oral Suspension
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
For a full list of excipients see section 6.1.
3 PHARMACEUTICAL FORM
Oral suspension.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cattle and sheep.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Parafend is a broad spectrum anthelmintic for the treatment and control of mature and developing immature gastro-
intestinal roundworms and lungworms and also ta
Leia o documento completo
